Oracle to acquire data management provider Phase Forward for $685M

Justine Varieur Cadet | | Health Imaging | Artificial Intelligence
Phase Forward, a provider of data management technologies for clinical trials and drug safety, has agreed to be acquired by Oracle for approximately $685 million.

The Waltham, Mass.-based Phase Forward management and employees are expected to join San Francisco-based Oracle as part of its health sciences global business unit. The combination is expected to allow researchers, clinical development professionals, physicians, regulators and patients to capture, contribute, access and share data, according to Oracle and Phase Forward.

"The life sciences and healthcare industries are converging as they seek to control costs while accelerating patient-centered innovation," said Neil de Crescenzo, senior vice president and general manager of Oracle’s health sciences unit.

The companies said the transaction is subject to stockholder and regulatory approval and other customary closing conditions and is expected to close in mid-2010.

Justine Varieur Cadet

Related Content

Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams
New study highlights the need to include more challenging datasets in AI training

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.